Phenobarbital Sodium Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 65 mg/mL, 130 mg/mL.

Reference Brands: Generic formulations marketed under different names

Category: Antipsychotropic Drugs

Phenobarbital Sodium is available in Injection and strengths such as 65 mg/mL, 130 mg/mL.. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Phenobarbital Sodium is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Phenobarbital Sodium can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Phenobarbital, also known as phenobarbitone, is a long-acting barbiturate medication widely used for its anticonvulsant and sedative properties. Marketed under the brand name Luminal and various generic equivalents, it is recognized by the World Health Organization as an essential medicine for the treatment of specific types of epilepsy, particularly in resource-limited and developing countries. In clinical practice, phenobarbital is commonly used to manage seizure disorders in infants and young children, while alternative therapies are often preferred for older pediatric and adult patients.

Phenobarbital can be administered orally, intramuscularly, or by slow intravenous infusion, depending on the clinical condition and urgency of treatment. Injectable forms are especially valuable in emergency settings, such as the management of status epilepticus when first-line therapies fail to produce adequate seizure control. Subcutaneous administration is not recommended.

Beyond epilepsy management, phenobarbital is used in selected cases for sedation, anxiety control, treatment of insomnia, and management of withdrawal symptoms associated with benzodiazepines and certain other drugs. It is also widely utilized in veterinary medicine. Following intravenous administration, onset of action occurs within minutes, while oral administration typically produces effects within thirty minutes, with a duration of action ranging from several hours to two days.